Scopus BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	0	2	28	198	89	89
Market Cap Growth	-	-92.69%	-85.73%	123.68%	0%	-
Enterprise Value	-0	2	20	199	89	89
PE Ratio	-0.21	-0.18	-1.02	-17.14	-32.96	-129.24
PB Ratio	-0.23	-0.31	7.04	-108.29	-1069.96	-16645.91
P/FCF Ratio	-0.47	-0.25	-2.48	-78.53	-41.73	-118.63
P/OCF Ratio	-0.71	-0.25	-2.48	-78.53	-41.81	-118.63
EV/EBITDA Ratio	-0.19	-0.17	-0.74	-19.57	-32.95	-129.24
EV/EBIT Ratio	-0.19	-0.17	-0.74	-19.57	-32.94	-
EV/FCF Ratio	-0.39	-0.24	-1.78	-78.71	-41.71	-118.63
Debt / Equity Ratio	0	0	0	-1.25	0	0
Debt / EBITDA Ratio	-	-	-	-0.22	-	-
Debt / FCF Ratio	-	-	-	-0.90	-	-
Quick Ratio	0.03	0.02	1.90	0.48	0.04	0.21
Current Ratio	0.05	0.05	1.96	0.52	0.90	0.96
Interest Coverage	0	0	-35.67	-14.38	0	0
Return on Equity (ROE)	92.00%	176.86%	-690.19%	631.75%	3246.42%	-
Return on Assets (ROA)	-1747.71%	-2959.69%	-338.65%	-586.04%	-348.58%	-
Return on Capital (ROIC)	27751.12%	178.46%	-687.86%	-2244.37%	3246.42%	-
Earnings Yield	-18784.32%	-561.61%	-98.00%	-5.83%	-3.03%	-0.77%
FCF Yield	-9921.75%	-393.19%	-40.39%	-1.27%	-2.40%	-0.84%
Buyback Yield / Dilution	-88.40%	-22.27%	-29.11%	10.77%	-	-
Total Shareholder Return	-88.40%	-22.27%	-29.11%	10.77%	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.